https://www.selleckchem.com/pr....oducts/tolebrutinib-
After the first knee surgery, medical complications were highest in the 24-week group. After the second knee, there were no significant difference in manipulation (P= .9), wound complications (P= .7), venous thromboembolism (P= .8), or other medical complications (P= 1) based on the interval duration. The interval between staged TKA did not affect early medical or surgical complications after the second stage. Early clinical and function results were not different based on timing of the second surgery. The interval be